Rite Aid announced that the NYSE informed the company that it is no longer in compliance with NYSE continued listing standards set forth in Section 802.01B and Section 802.01C of the NYSE’s Listed Company Manual. Under the NYSE rules, the company is provided with certain cure periods and the company’s common stock will continue to be listed and traded on the NYSE during the cure periods, subject to the company’s compliance with other continued listing requirements. The current noncompliance with the NYSE listing standards does not affect the company’s ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements, nor does it trigger any violation of its material debt or other obligations.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RAD:
- Novavax Stock (NASDAQ:NVAX) Surged After Winning the FDA’s Approval
- Unusually active option classes on open October 3rd
- Largest borrow rate increases among liquid names
- Walgreens Boots Alliance (NASDAQ:WBA) Surges on New Potential CEO
- Rite Aid planning to shut down hundreds of stores in bankruptcy, WSJ says
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue